← Back to Search

Behavioral Intervention

Avatar Therapy for Cannabis Use Disorder (Avatar-CUD Trial)

N/A
Waitlist Available
Led By Alexandre Dumais, MD, PhD
Research Sponsored by Ciusss de L'Est de l'Île de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week before treatment, within 1 week after treatment as well as 3- 6- and 12-months follow-up
Awards & highlights

Avatar-CUD Trial Summary

This trial tested a VR intervention to help people with psychotic/mood disorders reduce their cannabis use, improve quality of life. Results were promising.

Who is the study for?
This trial is for adults over 18 with severe mental health disorders like schizophrenia, schizoaffective disorder, bipolar disorder, or major depression who also have Cannabis Use Disorder as defined by the DSM-5. Participants must not be currently receiving treatment for CUD or detoxifying from cannabis and should not have neurological issues or unstable physical illnesses.Check my eligibility
What is being tested?
The study tests a new Virtual Reality (VR) Avatar Intervention aimed at reducing cannabis use and its associated problems in patients with certain psychotic and mood disorders. The focus is on seeing if this intervention can lessen the severity of CUD and improve quality of life.See study design
What are the potential side effects?
Since this is a VR-based psychological intervention rather than a drug, typical medication side effects are not expected. However, some participants may experience discomfort with VR such as dizziness or nausea.

Avatar-CUD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week before treatment, within 1 week after treatment as well as 3- 6- and 12-months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week before treatment, within 1 week after treatment as well as 3- 6- and 12-months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cannabis use (Timeline Follow-Back)
Secondary outcome measures
Change in psychiatric symptoms (Positive And Negative Syndrome Scale - PANSS)
Change in quality of life (Quality of Life Scale -QLS)
Change in the severity of the cannabis use disorder (Cannabis Use Problems Identification Test - CUPIT)
+1 more

Avatar-CUD Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Avatar InterventionExperimental Treatment1 Intervention
The Avatar Intervention will take place over 8 consecutive weeks, with one session per week. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use with the use of virtual reality and avatars.

Find a Location

Who is running the clinical trial?

Ciusss de L'Est de l'Île de MontréalLead Sponsor
70 Previous Clinical Trials
5,528 Total Patients Enrolled
Alexandre Dumais, MD, PhDPrincipal InvestigatorUniversity of Montreal, Institut universitaire en santé mentale de Montréal
2 Previous Clinical Trials
286 Total Patients Enrolled
Robert-Paul JusterStudy ChairUniversity of Montreal, Institut universitaire en santé mentale de Montréal

Media Library

Avatar Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05726617 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently occurring for this experiment?

"According to the details on clinicaltrials.gov, this research endeavor is no longer seeking new patients. It was originally posted on September 24th 2019 and most recently updated February 3rd 2023; however, there are over 1300 other trials that have open recruitment at present time."

Answered by AI
~6 spots leftby Apr 2025